What does LifeVantage Corp. do?

Jun 22 2025 06:09 PM IST
share
Share Via
LifeVantage Corporation specializes in bio-hacking aging through nutrigenomics in the Pharmaceuticals & Biotechnology sector, with a market cap of $159.87 million and quarterly net sales of $58 million. Key financial metrics include a P/E ratio of 17.00 and a dividend yield of 1.31%.
Overview:
LifeVantage Corporation is focused on bio-hacking the aging code through nutrigenomics, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
- Net Sales: 58 Million (Quarterly Results - Mar 2025)
- Net Profit: 3 Million (Quarterly Results - Mar 2025)
- Market cap: USD 159.87 Million (Micro Cap)

Key Metrics:
- P/E: 17.00
- Dividend Yield: 1.31%
- Debt Equity: -0.60
- Return on Equity: 26.91%
- Price to Book: 4.70

Contact Details:
- Address: 9785 S Monroe St Ste 300, SANDY UT : 84070-4282
- Tel: 1 801 4329000
- Website: http://www.lifevantage.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News